The syndrome we refer to as Hepatic Encephalopathy (HE) was first characterized by a team
of Nobel Prize winning physiologists led by Pavlov and Nencki at the Imperial Institute of …

Hepatic encephalopathy (HE) is a serious neuropsychiatric complication of cirrhosis and/or
porto-systemic shunting. The clinical symptoms are widely variable, extending from subtle …

Background & Aims The gut microbiome is altered in cirrhosis; however its evolution with
disease progression is only partly understood. We aimed to study changes in the …

Hepatic encephalopathy (HE) has been related to gut bacteria and inflammation in the
setting of intestinal barrier dysfunction. We aimed to link the gut microbiome with cognition …

Although hepatic encephalopathy (HE) is linked to the gut microbiota, stool microbiome
analysis has not found differences between HE and no-HE patients. This study aimed to …

Abstract Background and Aims Data on the use of intravenous L‐ornithine L‐aspartate
(LOLA) in the treatment of overt HE (OHE) is limited. We evaluated the role of intravenous …

Background Safety of individual probiotic strains approved under Investigational New Drug
(IND) policies in cirrhosis with minimal hepatic encephalopathy (MHE) is not clear. Aim The …

Hepatic encephalopathy (HE) is a serious complication of cirrhosis that causes
neuropsychiatric problems, such as cognitive dysfunction and movement disorders. The link …

Hepatic encephalopathy (HE) is a serious neuropsychiatric complication of both acute and
chronic liver disease. Symptoms of HE can include confusion, disorientation and poor …

Background & Aims Even after recovery from overt hepatic encephalopathy (HE), minimal
HE (MHE), which impairs quality of life (QoL), can persist. A double-blind, placebo-controlled …